Celltex News
Stem Cell Journals: Development of COVID‐19 Therapies from Birthing Tissues and Cord Blood
Posted on Oct 28th, 2020
Celltex Therapeutics Corporation was mentioned in the Stem Cell Journals publication in an article titled "Development of COVID‐19 Therapies from Birthing Tissues and Cord Blood".
Read the article
Tags: clinical research, clinical trial, COVID-19, stem cell therapy
More Recent News
What Makes MSCs So Promising? A Deep Dive on Mesenchymal Stem Cells
Present in the body throughout one’s lifespan, adult Mesenchymal Stem Cells (MSCs) can be used in many types of regenerative medicine. This article explores how MSCs work in the body and what makes them suitable for therapeutic application.
Read MoreStem Cell Therapy: How Are MSCs Administered to the Body?
Through the years, several stem cell therapy delivery methods have emerged. This article explores some of the most common routes of administration physicians may recommend today.
Read More